Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phenol-soluble modulin alpha is a short peptide toxin produced mainly by *Staphylococcus aureus*. It is an important virulence determinant due to its ability to lyse host immune cells, promote inflammation, assist biofilm dynamics, and help bacteria evade immune detection. Its structure—a bent amphipathic helix—enables membrane interaction leading to cytotoxic effects. The diversity among staphylococci reflects adaptation for both commensalism and pathogenicity. Detection relies on advanced chromatographic purification followed by mass spectrometry-based identification methods.
Membrane disruption, TLR2 activation via lipoprotein mobilization, modulation of dendritic cell activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phenol-soluble modulin alpha (PSMα).